Unconfigured Ad
Collapse
Discussion of next-gen sequencing related bioinformatics: resources, algorithms, open source efforts, etc
| Forums | Topics | Posts | Last Post |
|---|
No forums found.
There are no conversations in this channel.
Please log in to your account to view your subscribed posts.
| Topics | Statistics | Last Post | ||
|---|---|---|---|---|
|
Started by laura, 05-09-2011, 04:42 AM
|
35 responses
107,560 views
0 reactions
|
Last Post
by laura
12-05-2013, 02:37 AM
|
||
|
Started by sci_guy, 01-23-2008, 11:19 PM
|
236 responses
683,941 views
1 reaction
|
Last Post
by ECO
12-25-2009, 06:45 PM
|
||
|
Started by szy0931, 05-13-2016, 06:58 AM
|
8 responses
3,932 views
0 reactions
|
Last Post
by VC87
06-07-2016, 05:34 AM
|
||
|
Started by kmkocot, 06-06-2016, 09:30 AM
|
1 response
1,457 views
0 reactions
|
Last Post
by Ola
06-07-2016, 03:02 AM
|
||
|
Started by bvk, 06-07-2016, 12:44 AM
|
2 responses
2,629 views
0 reactions
|
Last Post
by bvk
06-07-2016, 01:58 AM
|
||
|
Started by AP38, 05-31-2016, 06:12 AM
|
4 responses
3,670 views
0 reactions
|
Last Post
by AP38
06-06-2016, 07:34 AM
|
||
|
Started by musta1234, 06-05-2016, 06:54 PM
|
1 response
1,639 views
0 reactions
|
Last Post
by yzzhang
06-06-2016, 04:29 AM
|
||
|
Started by jmwhitha, 04-23-2013, 05:51 AM
|
17 responses
16,166 views
0 reactions
|
Last Post
by jaredroach
06-05-2016, 02:06 PM
|
||
|
Started by guilhem, 06-05-2016, 06:48 AM
|
2 responses
2,382 views
0 reactions
|
Last Post
by guilhem
06-05-2016, 11:57 AM
|
||
|
Started by DuRoss, 06-04-2016, 11:41 PM
|
0 responses
1,163 views
0 reactions
|
Last Post
by DuRoss
06-04-2016, 11:41 PM
|
||
|
Started by AnushaC, 06-04-2016, 01:10 PM
|
1 response
1,937 views
0 reactions
|
Last Post
by AnushaC
06-04-2016, 01:18 PM
|
||
|
Started by macdecat, 05-24-2016, 03:06 PM
|
1 response
1,663 views
0 reactions
|
Last Post
by wdecoster
06-04-2016, 05:59 AM
|
No topics found.
-
Page of 0
-
Filter
widgetinstance 229 (Webinars) skipped due to lack of content & hide_module_if_empty option.
Recent Articles
Collapse
-
by SEQadmin2
Proteomics platforms are evolving rapidly, with advances in mass spectrometry and affinity-based approaches expanding what researchers can detect and at what scale. As the field moves toward deeper proteome coverage and clinical applications, scientists face an increasingly complex landscape of tools. This article will explore how researchers are navigating these choices to find the right platform for their work.
Introduction
The systematic characterization...-
Channel: Articles
Today, 10:07 AM -
-
by SEQadmin2
Genomics studies in neuroscience face a special challenge due to the brain’s complexity and scarcity of samples. Mapping changes in cell type and state using conventional next-generation sequencing methods remains challenging. Advances in technologies like single-cell sequencing, spatial transcriptomics, and long-read sequencing have opened the door to deeper studies of the brain and diseases like Alzheimer’s, amyotrophic lateral sclerosis (ALS), and schizophrenia.
...-
Channel: Articles
07-09-2026, 11:10 AM -
-
by SEQadmin2
Cancer survival rates have significantly increased in the last few decades in the United States, reaching a combined 70% 5-year survival rate by 2021. Behind this number, there are years of research to find new therapies, drug targets, and early detection methods. But there is one core challenge that keeps slowing down these advances, and it’s about drug resistance.
There is no single reason why many patients don’t respond to treatment as expected. Cancer is...-
Channel: Articles
07-08-2026, 05:17 AM -
ad_right_rmr
Collapse
News
Collapse
| Topics | Statistics | Last Post | ||
|---|---|---|---|---|
|
Started by SEQadmin2, Today, 11:10 AM
|
0 responses
1 view
0 reactions
|
Last Post
by SEQadmin2
Today, 11:10 AM
|
||
|
Started by SEQadmin2, 07-13-2026, 10:26 AM
|
0 responses
28 views
0 reactions
|
Last Post
by SEQadmin2
07-13-2026, 10:26 AM
|
||
|
Started by SEQadmin2, 07-09-2026, 10:04 AM
|
0 responses
38 views
0 reactions
|
Last Post
by SEQadmin2
07-09-2026, 10:04 AM
|